KRSA last traded at $37.56. On daily bars, all of the trend and momentum measures below are currently positive.
•The 50-day simple moving average is $32.30, so KRSA is trading above its 50-day average.
•The 200-day simple moving average is $23.66, so KRSA is trading above its 200-day average — the level most often used to separate a long-term uptrend from a downtrend.
•The 50-day average is above the 200-day, the configuration known as a golden cross.
•The 14-day RSI is 70.2 — above 70, which is conventionally read as overbought.
•The MACD line is 0.86 against a signal line of 0.25, so MACD is above its signal line.
•Over the past year KRSA has traded between $7.19 and $59.36, putting it 58% of the way up that range.
•Volume on the latest session was 265.2K shares against a 20-day average of 194.5K — 1.4× the average.
RSI (14)
70.2
Cyclerion Therapeutics, Inc.
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD.The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.